ERRIA OPJUSTERER FORVENTNINGERNE TIL ÅRETS RESULTAT
Selskabsmeddelelse Nr. 01/2023 – 27. februar 2023 Indeholder Insider information ERRIA OPJUSTERER FORVENTNINGERNE TIL ÅRETS RESULTAT ERRIA......
Agillic announces 2022 results with 37.7% growth in total
Announcement no. 1-2023 Contain insider information Copenhagen – 23 February 2023 - Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC)......
No. 1/2023 - Financial calendar 2023/2024
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K Copenhagen,......
NKT seeks to increase share issuance authorization at
Company Announcement 22 February 2023 Announcement No. 1 NKT seeks to increase share issuance authorization at Annual General Meeting The Board of......
Transactions by persons discharging managerial
Disclosure 1 / 2023 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely......
Upgraded outlook for 2023
Jyske Bank expects earnings per share of DKK 60-70, corresponding to a net profit of DKK 4.0bn - 4.6bn and a profit before tax of DKK 5.3bn - 6.1bn in......
Coloplast A/S - Allocation of Share Options
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market......
Regulatory filing for house dust mite allergy tablet
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy......
Coloplast A/S - Announcement no. 01/2023 – Interim
Q1 2022/23 Interim financial results, Q1 2022/23 1 October 2022 – 31 December 2022 Coloplast delivered a solid start to the year with 7%......
Addition to the Executive Management
To Nasdaq OMX Copenhagen A/S Public announcement no. 536 February 1st, 2023 ADDITION TO THE EXECUTIVE MANAGEMENT TEAM IN GLUNZ & JENSEN ......